4'-cyano-3-(4-fluorophenyl)propiophenone, 97.0%, 1g

Ethyl 4-hydroxyquinoline-2-carboxylate, 95.0%, 1g

4-Chloroquinazoline, 95.0%, 10g

2-(Benzyloxy)-2-methylpropan-1-ol, 97%, 5g

Sodium tungstate dihydrate, min. 99%, pa, ACS, 250 g, plastic packaging.

5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 250mg

1,2,3,4,6,7,8,9-Octahydrophenazine, 97%, 500mg

1-[2-(1H-1,2,4-triazol-1-yl)ethyl]piperazine trihydrochloride hydrate, 95.0%, 10g

Carbon Nanotube Multi-walled 20-40nm(diam.), 1-2micro m(length)1g

Dabigatran>95.0%(HPLC)500mg

((2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 98%, 250mg

2-N-phenylpyridine-2,4-diamine, 97%, 1g

METHYL 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLATE HCL, 95.0%, 250mg